| 2020-03-06 | Sale | Champions Oncology, Inc. CSBR | 10 percent owner | 708,155 6.1742% | $6.99 | $4.95M | +42.97% | |
| 2019-08-28 | Sale | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 2,422 0.006% | $2.91 | $7,048 | +203.64% | |
| 2019-03-05 | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 7.5M 23.242% | $4.00 | $30M | -3.05% | ||
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 6M 0.9744% | $1.67 | $10M | -57.66% | ||
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 12M 2.1988% | $1.92 | $23M | -12.28% | ||
| 2018-03-27 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 707,964 4.6641% | $2.70 | $1.91M | -8.89% | ||
| 2018-03-26 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.14M 0.2007% | $1.90 | $2.18M | -14.01% | ||
| 2018-03-23 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 588,180 0.1062% | $1.95 | $1.14M | -12.52% | ||
| 2018-03-22 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.74M 0.308% | $1.90 | $3.31M | -12.12% | ||
| 2018-03-21 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 209,688 0.0355% | $1.81 | $379,640 | -10.61% | ||
| 2017-11-27 | Sale | Appian Corporation APPN | 10 percent owner | 1.14M 2.1156% | $19.49 | $22.2M | +42.78% | |
| 2017-11-20 | Sale | Appian Corporation APPN | 10 percent owner | 5.64M 11.2735% | $19.49 | $109.94M | +53.66% | |
| 2017-07-03 | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 2M 9.7597% | $15.00 | $30M | +20.77% | ||
| 2017-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 25.74M 5.5147% | $0.70 | $18.02M | +55.36% | ||
| 2016-11-29 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 869,565 6.1674% | $5.75 | $5M | -41.3% | ||
| 2015-10-06 | Synlogic, Inc. SYBX | 10 percent owner | 857,142 4.1031% | $7.00 | $6M | -36.97% | ||
| 2015-02-04 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 1M 13.2854% | $10.00 | $10M | +15.99% |